# INBRIJA
> **NDA209184** · New Drug Application · Sponsor: MERZ · Approved 2018-12-21
## Drug
- **FDA Application Number:** NDA209184
- **Application type:** New Drug Application
- **Brand name:** INBRIJA
- **Generic name:** LEVODOPA
- **Active ingredients:** LEVODOPA
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** MERZ
- **Manufacturer:** Merz Pharmaceuticals, LLC
- **First approval:** 2018-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209184)
---
*AI Analytics · CC0 1.0*